期刊
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
卷 36, 期 1, 页码 30-36出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/jir.2015.0096
关键词
-
资金
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US
- NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER
IFN-4 is a novel type-III interferon with strong clinical significance in humans. Only a subset of individualsup to 10% of Asians, 50% of Europeans, and 90% of Africanscarry the G allele of a genetic variant rs368234815-TT/G and are genetically able to produce IFN-4 protein. Carriers of the G allele have impaired ability to clear infection with hepatitis C virus (HCV). IFN-4 is also predicted to exist and be functionally important in several nonhuman mammals. In this study, we present the first comparative analysis of 12 mammalian IFN-4 orthologs in a human hepatic cell line, HepG2, which supports signaling of the human IFN-4. We show that despite differences in protein sequences, functional properties of the recombinant human and nonhuman IFN-4 proteins are comparablethey are all expressed as predominantly cytoplasmic proteins that are biologically active for induction of interferon signaling. We show that several IFN-4 orthologs can be detected by Western blotting, flow cytometry, and confocal imaging using a monoclonal antibody developed for the human IFN-4. Studies of IFN-4 in animals should help improve our understanding of the biology of this novel clinically important interferon in normal and disease conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据